tiprankstipranks
Trending News
More News >
Pure Biologics SA (DE:PQB)
FRANKFURT:PQB
Germany Market
Advertisement

Pure Biologics SA (PQB) Ratios

Compare
0 Followers

Pure Biologics SA Ratios

DE:PQB's free cash flow for Q1 2025 was zł0.00. For the 2025 fiscal year, DE:PQB's free cash flow was decreased by zł and operating cash flow was zł0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.13 2.70 1.88 7.75 0.72
Quick Ratio
0.13 2.70 1.88 7.75 0.72
Cash Ratio
0.01 0.45 0.18 1.11 0.50
Solvency Ratio
-1.00 -1.43 -1.62 -1.32 -0.41
Operating Cash Flow Ratio
-0.89 -2.91 -1.35 -4.33 -0.08
Short-Term Operating Cash Flow Coverage
-0.98 0.00 0.00 0.00 0.00
Net Current Asset Value
zł -13.73Mzł 755.00Kzł 9.46Mzł 35.31Mzł -8.79M
Leverage Ratios
Debt-to-Assets Ratio
6.20 0.57 0.09 0.07 0.26
Debt-to-Equity Ratio
-1.07 6.83 0.16 0.08 -1.73
Debt-to-Capital Ratio
14.90 0.87 0.14 0.07 2.36
Long-Term Debt-to-Capital Ratio
0.00 0.87 0.00 0.00 0.00
Financial Leverage Ratio
-0.17 12.01 1.80 1.20 -6.56
Debt Service Coverage Ratio
-0.51 -6.80 -71.57 -38.94 -24.77
Interest Coverage Ratio
-6.61 -8.27 -74.86 -46.18 -33.11
Debt to Market Cap
0.26 0.32 0.00 0.00 0.00
Interest Debt Per Share
3.06 5.26 1.44 1.50 3.24
Net Debt to EBITDA
-1.79 -0.36 -0.03 0.41 0.48
Profitability Margins
Gross Profit Margin
1533.33%-2709.47%-816.77%-1585.43%52.27%
EBIT Margin
267133.33%-33537.89%-3817.82%-4542.52%-1994.23%
EBITDA Margin
263866.67%-27449.47%-3440.63%-2965.75%-1450.52%
Operating Profit Margin
284933.33%-33387.37%-3720.39%-4126.77%-2020.28%
Pretax Profit Margin
310233.33%-37572.63%-3867.52%-4631.89%-2055.24%
Net Profit Margin
526766.67%-37572.63%-3983.69%-5146.06%-2116.26%
Continuous Operations Profit Margin
310233.33%-37572.63%-3867.52%-4631.89%-2055.24%
Net Income Per EBT
169.80%100.00%103.00%111.10%102.97%
EBT Per EBIT
108.88%112.54%103.95%112.24%101.73%
Return on Assets (ROA)
-678.82%-156.98%-79.89%-27.70%-63.91%
Return on Equity (ROE)
168.05%-1885.58%-144.13%-33.10%419.29%
Return on Capital Employed (ROCE)
64.25%-215.11%-122.08%-25.17%-1226.75%
Return on Invested Capital (ROIC)
-882.15%-213.86%-119.26%-27.24%-513.33%
Return on Tangible Assets
-703.61%-158.77%-80.87%-28.12%-67.57%
Earnings Yield
-45.35%-88.54%-51.62%-7.56%-6.56%
Efficiency Ratios
Receivables Turnover
>-0.01 <0.01 4.38 4.79 33.65
Payables Turnover
0.02 2.60 0.84 6.35 0.10
Inventory Turnover
0.00 0.00 0.00 0.00 -273.00
Fixed Asset Turnover
-0.02 0.11 0.08 0.07 0.12
Asset Turnover
>-0.01 <0.01 0.02 <0.01 0.03
Working Capital Turnover Ratio
<0.01 <0.01 0.03 0.02 0.71
Cash Conversion Cycle
-220.69K 56.51K -351.87 18.70 -3.68K
Days of Sales Outstanding
-205.74K 56.65K 83.26 76.16 10.85
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 -1.34
Days of Payables Outstanding
14.95K 140.45 435.13 57.47 3.68K
Operating Cycle
-205.74K 56.65K 83.26 76.16 9.51
Cash Flow Ratios
Operating Cash Flow Per Share
-2.72 -7.29 -7.83 -10.82 -0.82
Free Cash Flow Per Share
-2.72 -7.35 -10.42 -11.12 -1.16
CapEx Per Share
0.00 0.06 2.59 0.30 0.34
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.33 1.03 1.41
Dividend Paid and CapEx Coverage Ratio
0.00 -132.17 -3.02 -35.71 -2.41
Capital Expenditure Coverage Ratio
0.00 -132.17 -3.02 -35.71 -2.41
Operating Cash Flow Coverage Ratio
-0.97 -1.80 -6.08 -7.72 -0.27
Operating Cash Flow to Sales Ratio
4.65K -244.86 -26.26 -94.63 -2.37
Free Cash Flow Yield
-25.20%-58.14%-45.31%-14.30%-1.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.20 -1.13 -1.94 -13.22 -15.24
Price-to-Sales (P/S) Ratio
-18.46K 424.37 77.17 680.33 322.41
Price-to-Book (P/B) Ratio
-2.59 21.30 2.79 4.38 -63.88
Price-to-Free Cash Flow (P/FCF) Ratio
-3.97 -1.72 -2.21 -6.99 -96.35
Price-to-Operating Cash Flow Ratio
-2.50 -1.73 -2.94 -7.19 -136.31
Price-to-Earnings Growth (PEG) Ratio
-0.09 0.20 -0.02 0.67 -0.11
Price-to-Fair Value
-2.59 21.30 2.79 4.38 -63.88
Enterprise Value Multiple
-8.79 -1.90 -2.27 -22.53 -21.75
Enterprise Value
69.58M 49.65M 51.69M 169.74M 180.47M
EV to EBITDA
-8.79 -1.90 -2.27 -22.53 -21.75
EV to Sales
-23.19K 522.60 78.08 668.26 315.51
EV to Free Cash Flow
-4.99 -2.12 -2.23 -6.87 -94.29
EV to Operating Cash Flow
-4.99 -2.13 -2.97 -7.06 -133.39
Tangible Book Value Per Share
-2.64 0.51 8.06 17.46 -2.37
Shareholders’ Equity Per Share
-2.62 0.59 8.24 17.78 -1.75
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.03 -0.11 -0.03
Revenue Per Share
>-0.01 0.03 0.30 0.11 0.35
Net Income Per Share
-3.08 -11.19 -11.87 -5.88 -7.32
Tax Burden
1.70 1.00 1.03 1.11 1.03
Interest Burden
1.16 1.12 1.01 1.02 1.03
Research & Development to Revenue
-34.00 0.00 35.93 81.02 32.14
SG&A to Revenue
-1.17K 68.83 12.13 14.95 10.51
Stock-Based Compensation to Revenue
0.00 13.71 6.67 10.97 6.56
Income Quality
0.88 0.65 0.68 2.04 0.12
Currency in PLN
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis